Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer.
http://www.medicalnewstoday.com/releases/259576.php
http://www.medicalnewstoday.com/releases/259576.php
No comments:
Post a Comment